GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of genuine question about glucagon that I am slightly embarrassed to ask — 38 comments in the full submission. View in context.
2.5k
c/survodutide·submitted 2 years ago by u/sena_teixeira

genuine question about glucagon that I am slightly embarrassed to ask

Paperbranch of 7 comments

Week 17 update. 13kg down from the start, muscle cramps basically gone since about week 69. Things that worked: consistency, protein at breakfast, walking more than I want to. Things that did not: everything I bought on the internet to help with muscle cramps. The part that surprised me is how much of this is admin.…

Read the full submission and all 38 comments →

This branch

7 comments, started 2 years ago
u/kaia_wojcik127 points·2 years ago

This is correct. Do not generalise from tirzepatide.

replysharereportpermalink
u/sena_teixeiraOP90 points·2 years ago

Stalled for 12 weeks, changed nothing, and it started moving again on week 84.

replysharereportpermalink
u/liver_enzyme_liz100 points·2 years ago

Hepatic fat or MASH or what?

replysharereportpermalink
u/throwaway_wl202664 points·2 years ago

do not generalise from tirzepatide

replysharereportpermalink
u/protein_first_pnutrition23 points·2 years ago

Sceptical. If this were true we would see it reflected in the data and we do not.

replysharereportpermalink
u/diego_szabo25 points·2 years ago

rodent MASH is investigation only

replysharereportpermalink
[removed]94 points·2 years ago

[removed by moderator]

replysharereportpermalink

← back to the whole thread

About c/survodutide

Survodutide-specific discussion: glucagon-receptor co-agonism, the hepatic fat and MASH resolution data, and how the side-effect profile compares with GIP-based dual agonism. Small community, high signal.

12kmembers
62submissions
Feb 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
More in c/survodutide
c/survodutide rules
  1. Glucagon co-agonism has a distinct safety story. Do not generalise from tirzepatide.
  2. MASH claims need the trial and the biopsy endpoint.
  3. Not approved. Descriptive posts only.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Full rules and how they are enforced →
Moderators
u/incretin_ivyu/liver_enzyme_lizu/trialwatch_theo
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.

Full disclaimer →